Association between
cytokine
interleukin
meta-analysis
oral carcinoma
oral cavity cancer
polymorphism
Journal
Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208
Informations de publication
Date de publication:
22 Apr 2021
22 Apr 2021
Historique:
received:
06
04
2021
revised:
17
04
2021
accepted:
19
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
15
5
2021
Statut:
epublish
Résumé
Inflammation and cell-mediated immunity can have significant roles in different stages of carcinogenesis. The present meta-analysis aimed to evaluate the association between the polymorphisms of PubMed/MEDLINE, Web of Science, Cochrane Library, and Scopus databases were searched until December 18, 2020 without any restrictions. RevMan 5.3 software was used to calculate the results of forest plots (odds ratios (ORs) and 95% confidence intervals (CIs)); CMA 2.0 software was used to calculate funnel plots (Begg's and Egger's tests), and SPSS 22.0 was used for the meta-regression analysis. Moreover, trial sequential analysis was conducted to estimate the robustness of the results. Eleven articles including twelve studies were selected for the meta-analysis. The pooled ORs for the association between The meta-analysis confirmed that there was no association between the polymorphisms of
Sections du résumé
BACKGROUND AND OBJECTIVE
OBJECTIVE
Inflammation and cell-mediated immunity can have significant roles in different stages of carcinogenesis. The present meta-analysis aimed to evaluate the association between the polymorphisms of
METHODS
METHODS
PubMed/MEDLINE, Web of Science, Cochrane Library, and Scopus databases were searched until December 18, 2020 without any restrictions. RevMan 5.3 software was used to calculate the results of forest plots (odds ratios (ORs) and 95% confidence intervals (CIs)); CMA 2.0 software was used to calculate funnel plots (Begg's and Egger's tests), and SPSS 22.0 was used for the meta-regression analysis. Moreover, trial sequential analysis was conducted to estimate the robustness of the results.
RESULTS
RESULTS
Eleven articles including twelve studies were selected for the meta-analysis. The pooled ORs for the association between
CONCLUSIONS
CONCLUSIONS
The meta-analysis confirmed that there was no association between the polymorphisms of
Identifiants
pubmed: 33922260
pii: medicina57050405
doi: 10.3390/medicina57050405
pmc: PMC8146036
pii:
doi:
Substances chimiques
Interleukin-6
0
Interleukin-8
0
Types de publication
Journal Article
Meta-Analysis
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Références
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
BMJ Open. 2016 Aug 12;6(8):e011890
pubmed: 27519923
Pain. 1995 Dec;63(3):289-302
pubmed: 8719529
Oral Oncol. 2010 Jun;46(6):414-7
pubmed: 20400366
Lancet Oncol. 2008 Jul;9(7):667-75
pubmed: 18598931
Lancet. 2008 May 17;371(9625):1695-709
pubmed: 18486742
Auris Nasus Larynx. 2008 Sep;35(3):381-9
pubmed: 18276095
J Interferon Cytokine Res. 2019 Dec;39(12):727-739
pubmed: 31314647
Tumour Biol. 2014 Sep;35(9):9211-8
pubmed: 24929327
Clin Biochem. 2004 May;37(5):363-9
pubmed: 15087251
Cancer Causes Control. 2007 May;18(4):449-55
pubmed: 17356794
Cancer Commun (Lond). 2020 Mar;40(2-3):81-92
pubmed: 32067418
J Natl Cancer Inst. 1959 Apr;22(4):719-48
pubmed: 13655060
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Cancers (Basel). 2019 Apr 07;11(4):
pubmed: 30959967
Int J Biol Markers. 2006 Oct-Dec;21(4):246-50
pubmed: 17177164
Crit Rev Ther Drug Carrier Syst. 2016;33(4):363-400
pubmed: 27910740
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Oral Oncol. 2009 Apr-May;45(4-5):309-16
pubmed: 18804401
Int J Hyg Environ Health. 2010 Mar;213(2):146-52
pubmed: 20133197
Rural Remote Health. 2009 Apr-Jun;9(2):1118
pubmed: 19445556
Pharm Res. 2008 Sep;25(9):2097-116
pubmed: 18626751
J Biol Chem. 2000 Jun 16;275(24):18138-44
pubmed: 10747905
J Clin Oncol. 2001 Jan 15;19(2):577-83
pubmed: 11208853
Oral Oncol. 2011 Jul;47(7):642-7
pubmed: 21612975
Clin Cancer Res. 2004 Nov 1;10(21):7157-62
pubmed: 15534087
Harefuah. 2017 Oct;156(10):645-649
pubmed: 29072384
J Clin Oncol. 2011 Nov 10;29(32):4294-301
pubmed: 21969503
Mutagenesis. 2011 Sep;26(5):637-42
pubmed: 21653279
Oral Oncol. 2000 May;36(3):256-63
pubmed: 10793327
J UOEH. 2010 Sep 1;32(3):221-36
pubmed: 20857816
Oral Dis. 2012 Apr;18(3):307-14
pubmed: 22151543
Meta Gene. 2015 May 15;4:142-51
pubmed: 26005639
CA Cancer J Clin. 2002 Jul-Aug;52(4):195-215
pubmed: 12139232
Gene. 2013 Jun 15;522(2):168-76
pubmed: 23545310
Indian J Public Health. 2012 Jan-Mar;56(1):57-60
pubmed: 22684175
J Dent Res. 2015 Mar;94(3):403-11
pubmed: 25582438
Brain Res. 1994 Aug 15;654(1):15-26
pubmed: 7982088
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Interferon Cytokine Res. 2020 Jul;40(7):357-369
pubmed: 32598201
Oral Dis. 2011 Oct;17(7):720-6
pubmed: 21771210
J Oral Pathol Med. 2018 Mar;47(3):268-274
pubmed: 29272054
Int J Clin Exp Pathol. 2015 Sep 01;8(9):11884-94
pubmed: 26617944
Cell. 2010 Mar 19;140(6):883-99
pubmed: 20303878
Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5996-6001
pubmed: 14676125
J Cancer Res Clin Oncol. 2008 Aug;134(8):821-32
pubmed: 18273643
Oral Oncol. 2013 Sep;49(9):887-892
pubmed: 23910564
Biochem Genet. 2016 Feb;54(1):95-106
pubmed: 26660080
Oral Oncol. 2010 Jun;46(6):411-3
pubmed: 20381409
BMC Med Res Methodol. 2017 Mar 6;17(1):39
pubmed: 28264661
Arch Oral Biol. 2019 Dec;108:104547
pubmed: 31525531
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120